Almond Intervention in Type 2 Diabetes Mellitus
Primary Purpose
Cardiovascular Diseases
Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
almond
Sponsored by
About this trial
This is an interventional prevention trial for Cardiovascular Diseases
Eligibility Criteria
Inclusion Criteria:
- Patients in the age range of 25-65 years
- on stable doses of metformin from past 3 months
- having HbA1C less than 9%
- LDL-c ≥100 mg/dl were recruited
Exclusion Criteria:
- Patients on insulin therapy, plioglitazone, insulin secretagogues, beta blockers or steroids or suffering from diabetes for more than 10 years
- having high uric acid levels (≥ 8 mg/dl),
- with accelerated hypertension (stage 2 hypertension according to JNC guidelines) , hypothyroidism, suffering from acute infection or any debilitating disease or with renal failure,
- appreciable weight loss (more than 10%) during past 6 months
- Patients with known food allergy, lipid altering medication or extraneous factors that can affect glycemic or lipid parameters
Sites / Locations
- Fortis Flt Lt Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
almond
Arm Description
almonds are substituted for visible fat and carbohydrates
Outcomes
Primary Outcome Measures
Change in LDL-c
Secondary Outcome Measures
HbA1C
Full Information
NCT ID
NCT02027740
First Posted
January 3, 2014
Last Updated
January 3, 2014
Sponsor
Diabetes Foundation, India
1. Study Identification
Unique Protocol Identification Number
NCT02027740
Brief Title
Almond Intervention in Type 2 Diabetes Mellitus
Official Title
Effect of Almond Supplementation on Glycemic and Cardiovascular Risk Factors in Asian Indians in North India With Type 2 Diabetes Mellitus: A 24-week Prospective Cohort Study
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
February 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Diabetes Foundation, India
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This prospective cohort study of an almond-enriched diet (within the overall context of Asian Indian dietary guidelines) was conducted to test the hypothesis that in patients with T2DM almond-enriched balanced diet improves glycemic measures and CVD risk factors.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
almond
Arm Type
Experimental
Arm Description
almonds are substituted for visible fat and carbohydrates
Intervention Type
Dietary Supplement
Intervention Name(s)
almond
Primary Outcome Measure Information:
Title
Change in LDL-c
Time Frame
baseline, after six months
Secondary Outcome Measure Information:
Title
HbA1C
Time Frame
baseline, after six months of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients in the age range of 25-65 years
on stable doses of metformin from past 3 months
having HbA1C less than 9%
LDL-c ≥100 mg/dl were recruited
Exclusion Criteria:
Patients on insulin therapy, plioglitazone, insulin secretagogues, beta blockers or steroids or suffering from diabetes for more than 10 years
having high uric acid levels (≥ 8 mg/dl),
with accelerated hypertension (stage 2 hypertension according to JNC guidelines) , hypothyroidism, suffering from acute infection or any debilitating disease or with renal failure,
appreciable weight loss (more than 10%) during past 6 months
Patients with known food allergy, lipid altering medication or extraneous factors that can affect glycemic or lipid parameters
Facility Information:
Facility Name
Fortis Flt Lt Hospital
City
Delhi
Country
India
12. IPD Sharing Statement
Learn more about this trial
Almond Intervention in Type 2 Diabetes Mellitus
We'll reach out to this number within 24 hrs